Investors Opt Out Of Pfizer Securities Fraud Class Action
A group of investors opted out of a securities fraud class action against Pfizer Inc. and filed its own suit Thursday in New York federal court alleging the pharmaceutical giant concealed...To view the full article, register now.
Already a subscriber? Click here to view full article